Sun Pharma Q2: Cons Net Profit At Rs 1,108.7 Cr Vs CNBC-TV18 Poll Of Rs 1,298 Cr
Sun Pharma Q2: Cons Net Sales At Rs 6,803.3 Cr Vs CNBC-TV18 Poll Of Rs 6,940.9 Cr
Sun Pharma Q2: Cons EBITDA At Rs 1,899 Cr Vs CNBC-TV18 Poll Of Rs 1,895 Cr
Sun Pharma Q2: Cons EBITDA Margin At 27.9% Vs CNBC-TV18 Poll Of 27%
Sun Pharma Q2: Cons Net Sales Up 4.3% At Rs 6,803.3 Cr (QoQ)
Sun Pharma Q2: Cons EBITDA Margin At 27.9% Vs 25.2% (QoQ)
Sun Pharma Q2: Cons EBITDA Up 15.6% At Rs 1,899 Cr (QoQ)
Sun Pharma Q2: Cons Net Sales At Rs 6,803.3 Cr Vs CNBC-TV18 Poll Of Rs 6,940.9 Cr
Sun Pharma Q2: Cons EBITDA At Rs 1,899 Cr Vs CNBC-TV18 Poll Of Rs 1,895 Cr
Sun Pharma Q2: Cons EBITDA Margin At 27.9% Vs CNBC-TV18 Poll Of 27%
Sun Pharma Q2: Cons Net Sales Up 4.3% At Rs 6,803.3 Cr (QoQ)
Sun Pharma Q2: Cons EBITDA Margin At 27.9% Vs 25.2% (QoQ)
Sun Pharma Q2: Cons EBITDA Up 15.6% At Rs 1,899 Cr (QoQ)
No comments:
Post a Comment